The Facts About Mounjaro Worth Knowing Before You Decide

What kind of medicine Mounjaro actually is, and why the mechanism matters to your decision

Tirzepatide, sold as Mounjaro by Eli Lilly, works by mimicking two hormones your gut releases after eating: GIP and GLP-1. Stimulating both pathways together slows how quickly food leaves your stomach, dials down appetite signals in the brain, and improves how the body handles blood sugar. Older injections in this space (semaglutide, liraglutide) target GLP-1 alone. The dual-receptor action is the reason tirzepatide has consistently produced larger average weight reductions in trials than single-agonist treatments, a point the NICE appraisal of tirzepatide addresses in detail when reviewing the head-to-head evidence.

Each Mounjaro pen is a pre-filled KwikPen delivering four weekly doses from a single device. UK strengths run from 2.5mg through to 15mg in six steps. The 2.5mg starting dose is a tolerability measure, its job is giving your digestive system several weeks to adjust before the dose rises. Your prescriber sets the titration schedule; the patient information leaflet covers what happens at each stage. If you want to understand the broader landscape of tirzepatide before a consultation, the overview of tirzepatide covers the mechanism in more depth.

Storage matters: Mounjaro must be kept refrigerated between 2°C and 8°C. The SmPC sets out a limited room-temperature window for when a pen is in use, always check the leaflet rather than relying on a figure quoted online, because the rules differ between products and pen age.

The eligibility picture, and the one thing BMI alone doesn't settle

The licensed eligibility criteria are straightforward on paper: adults, BMI of 30 or above, or 27 or above with at least one weight-related condition such as high blood pressure, high cholesterol, type 2 diabetes, obstructive sleep apnoea or prediabetes. Lower BMI thresholds apply for some ethnic backgrounds under UK guidance. But a number alone is never the whole story. A prescriber reviews your full health picture (current medicines, medical history, any contraindications) before authorising treatment. BMI gets you to the consultation; the clinical assessment decides whether Mounjaro is appropriate for you specifically.

NICE recommended tirzepatide for NHS use in December 2024 (TA1026), setting a higher bar for public funding: BMI of 35 or above plus at least one weight-related comorbidity, with a phased rollout tied to additional conditions. That NHS threshold is stricter than the licensed criteria, which is why people who are clinically eligible under the licence but don't yet qualify for NHS treatment often explore the private route. The Mounjaro treatment page explains how the private consultation process works at nume.

One practical check worth doing before you fill in any form: look up the pharmacy you're considering on the GPhC pharmacy register. It takes under a minute and confirms the premises are registered and regulated. Any seller that cannot be found there is one to avoid, regardless of how the website looks.

Side effects, an honest account of what the evidence shows

The most commonly reported side effects are gastrointestinal: nausea, vomiting, diarrhoea, constipation, indigestion and reflux. These tend to peak after starting treatment or following a dose increase, and for most people they settle within days to a couple of weeks. Injection-site reactions, fatigue, headache and dizziness also appear in trial data, though with lower frequency.

Two areas deserve specific attention. First, pancreatitis: the MHRA issued a Drug Safety Update in January 2026 flagging acute pancreatitis as an infrequent but potentially serious effect of GLP-1 medicines. Severe stomach pain that radiates toward the back, especially with vomiting, needs prompt medical assessment, it should not be waited out. Second, contraception: women taking an oral contraceptive pill should add a non-oral method for the first four weeks of Mounjaro treatment and for four weeks after each dose increase, because tirzepatide's effect on gastric emptying may reduce pill absorption. The NHS tirzepatide page sets out the full list of known side effects and what to do about them. Patients can report unexpected effects directly through Yellow Card.

The Black Triangle (▼) on Mounjaro's licence reflects the fact that it is still under enhanced monitoring, not that it is considered unsafe, but that the MHRA wants a richer post-market dataset. That is standard for medicines approved in recent years. For more on what recent clinical updates mean for people considering treatment, the latest Mounjaro news covers developments as they emerge.

Cost context and what the prescription process involves

Mounjaro is not available free on the NHS to most people yet, the phased rollout under NICE TA1026 is limited to specific criteria, and GP practices are only beginning to participate. For those pursuing private treatment, prices vary by dose and provider. Eli Lilly raised its UK list price significantly from September 2025, and typical private costs since then have ranged roughly £149 to £375 per month depending on the dose and where you obtain it. Any legitimate quote includes a prescription following clinical assessment; if a price appears without those components, the shortcut is usually the clinical review.

The background on the Eli Lilly UK price increase is worth reading if cost is a primary concern, because it explains why the market shifted and what current pricing reflects. If you are still weighing up whether this medicine is right for you, our Mounjaro facts page brings together the key clinical and practical points in one place. On the topic of what a full private service should cover, the weight-loss treatments page outlines what is included at nume (consultation, prescription, aftercare and delivery) in a single transparent price with no subscription attached.

Mounjaro is a prescription-only medicine. That means a qualified prescriber, not a checkout process, is the gate. If you would like a clearer picture of what tirzepatide is and how it works before booking, that page walks through the science in plain language. Speak to our prescribers through a free consultation and get a same-day clinical decision on whether Mounjaro is clinically appropriate for you.